Re: Proton Pump Inhibitors and Risk for Recurrent Clostridium difficile Infection Among Inpatients

被引：2
作者：
Abdalla, Jason [1 ]
Hassan, Tuyyab [1 ]
Kyprianou, Annette [1 ]
机构：
[1] Metrohlth Med Ctr, Dept Gastroenterol, Cleveland, OH 44109 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2014年 / 109卷 / 04期
关键词：
EROSIVE ESOPHAGITIS; ESOMEPRAZOLE; DIARRHEA; FLUOROQUINOLONES; LANSOPRAZOLE; ANTIBIOTICS; OMEPRAZOLE; EFFICACY; DISEASE; SAFETY;
D O I：
10.1038/ajg.2013.481
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：601 / 602
页数：3
相关论文
共 11 条
  • [1] Castell DO, 2002, AM J GASTROENTEROL, V97, P575
  • [2] Community-associated Clostridium difficile infection and antibiotics: a meta-analysis
    Deshpande, Abhishek
    Pasupuleti, Vinay
    Thota, Priyaleela
    Pant, Chaitanya
    Rolston, David D. K.
    Sferra, Thomas J.
    Hernandez, Adrian V.
    Donskey, Curtis J.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (09) : 1951 - 1961
  • [3] Are broad-spectrum fluoroquinolones more likely to cause Clostridium difficile-associated disease?
    Dhalla, Irfan A.
    Mamdani, Muhammad M.
    Simor, Andrew E.
    Kopp, Alex
    Rochon, Paula A.
    Juurlink, David N.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (09) : 3216 - 3219
  • [4] Proton Pump Inhibitors and Risk for Recurrent Clostridium difficile Infection Among Inpatients
    Freedberg, Daniel E.
    Salmasian, Hojjat
    Friedman, Carol
    Abrams, Julian A.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (11) : 1794 - 1801
  • [5] CLOSTRIDIUM-DIFFICILE ASSOCIATED DIARRHEA AND COLITIS IN ADULTS - A PROSPECTIVE CASE-CONTROLLED EPIDEMIOLOGIC-STUDY
    GERDING, DN
    OLSON, MM
    PETERSON, LR
    TEASLEY, DG
    GEBHARD, RL
    SCHWARTZ, ML
    LEE, JT
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1986, 146 (01) : 95 - 100
  • [6] Johnson DA, 2001, AM J GASTROENTEROL, V96, P27
  • [7] A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality
    Loo, VG
    Poirier, L
    Miller, MA
    Oughton, M
    Libman, MD
    Michaud, S
    Bourgault, AM
    Nguyen, T
    Frenette, C
    Kelly, M
    Vibien, A
    Brassard, P
    Fenn, S
    Dewar, K
    Hudson, TJ
    Horn, R
    René, P
    Monczak, Y
    Dascal, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (23) : 2442 - 2449
  • [8] Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: A five-way crossover study
    Miner, P
    Katz, PO
    Chen, YS
    Sostek, M
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (12) : 2616 - 2620
  • [9] Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea:: A cohort study during an epidemic in Quebec
    Pépin, J
    Saheb, N
    Coulombe, MA
    Alary, ME
    Corriveau, MP
    Authier, S
    Leblanc, M
    Rivard, G
    Bettez, M
    Primeau, V
    Nguyen, M
    Jacob, CE
    Lanthier, L
    [J]. CLINICAL INFECTIOUS DISEASES, 2005, 41 (09) : 1254 - 1260
  • [10] Richter JE, 2001, AM J GASTROENTEROL, V96, P656
12